CMIP is oncogenic in human gastric cancer cells
Researchers find c‑Maf inducing protein (CMIP) could be a novel target in the clinical therapeutic management of gastric cancer.
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE